Procter & Gamble’s (PG) 1Q revenue came in at $20.34B versus an estimated $19.85B. Arun Sundaram, Equity Research Analyst at CFRA Research, discusses the Procter & Gamble earnings report, as it was released today, October 19th, premarket. PG’s 1Q organic sales growth is up 4%, and its 1Q biggest sales increase was in the healthcare unit. Additionally, CFRA has a buy rating and raised its price target to $157 from $155 on Procter & Gamble. Tune in to find out more.
Morning Trade Live
19 Oct 2021
SHARE
Morning Trade Live
06 Oct 2022
Morning Trade Live
12 Oct 2022
The Watch List
07 Aug 2022
Market On Close
30 Aug 2022
Trading 360
12 Aug 2022